STAT3 and glioblastoma: In our study, we found and described a HOXD‐AS2‐STAT3 positive feedback loop which attenuated temozolomide sensitivity in glioblastoma, indicating that this loop might be targeted as a novel therapeutic strategy for glioblastoma.